Charlotte AHEC, Charlotte, North Carolina, USA.
UW Diabetes Institute, University of Washington, Seattle, Washington, USA.
Diabetes Technol Ther. 2021 Sep;23(S3):S12-S18. doi: 10.1089/dia.2021.0191.
Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring (CGM) use in individuals with type 1 diabetes and type 2 diabetes (T2D) who are treated with intensive insulin therapy. A growing body of evidence suggests that CGM use may also confer similar glycemic benefits in T2D individuals who are treated with less-intensive therapies. Investigators are also exploring the potential use of CGM as an aid in weight management. This article reviews the continuing evolution of CGM, focusing on how CGM may be used to improve glycemic control and promote adoption of desired health behaviors within broader T2D and prediabetes populations.
许多研究表明，在接受强化胰岛素治疗的 1 型糖尿病和 2 型糖尿病（T2D）患者中，连续血糖监测（CGM）的使用具有临床益处。越来越多的证据表明，在接受不太强化治疗的 T2D 个体中，CGM 的使用也可能带来类似的血糖益处。研究人员还在探索 CGM 在体重管理中的潜在用途。本文综述了 CGM 的不断发展，重点介绍了 CGM 如何用于改善血糖控制，并在更广泛的 T2D 和糖尿病前期人群中促进理想健康行为的采用。
